GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

GSK ADC gets FDA breakthrough therapy designation

GSK’s Nucala approved in China for use in CRSwNP

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

GlaxoSmithKline PLC (GSK LN)

GSK ADC gets FDA breakthrough therapy designation

GSK’s Nucala approved in China for use in CRSwNP

Total Voting Rights

Director/PDMR Shareholding

Block Listing Application

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)